Mortality benefit and reduced need for repeat revascularization with statin therapy among patients undergoing percutaneous coronary intervention

Journal of Cardiology

Volumn 57, Issue 3, 2011, Pages 360-

  Zhang, Zhi Jiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACCURACY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; LETTER; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REPEAT PROCEDURE; RISK REDUCTION; STATISTICAL ANALYSIS; VALIDITY;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MORTALITY; MYOCARDIAL REVASCULARIZATION; REOPERATION;

EID: 79955000747     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.01.006     Document Type: Letter

References (4)

1. Nakamura M., Yamashita T., Yajima J., Oikawa Y., Ogasawara K., Sagara K., Koike A., Kirigaya H., Nagashima K., Otsuka T., Uejima T., Funada R., Matsuno S., Suzuki S., Sawada H., et al. Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol 2011, 57:172-180.
2. Zhang Z.J., Marroquin O.C., Weissfeld J.L., Stone R.A., Mulukutla S.R., Williams D.O., Selzer F., Kip K.E. Beneficial effects of statins after percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil 2009, 16:445-450.
3. Zhang Z.J., Cheng Q., Jiang G.X., Marroquin O.C. Statins in prevention of repeat revascularization after percutaneous coronary intervention-a meta-analysis of randomized clinical trials. Pharmacol Res 2010, 61:316-320.
4. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.